Sergio Fazio

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Jan Borén, M. John Chapman, Ronald M. Krauss et al. · European Heart Journal · 2020 · 1.4K citations

Therapeutic Insights, Vascular Disease, Epidemiology +13

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit et al. · Endocrine Practice · 2017 · 1.1K citations

Metabolic Syndrome, Cardiovascular Disease, Health Policy +7

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Michelle L. O’Donoghue, Sergio Fazio, Robert P. Giugliano et al. · Circulation · 2019 · 895 citations · Full text

Variation in<i>PCSK9</i>and<i>HMGCR</i>and Risk of Cardiovascular Disease and Diabetes

Brian A. Ference, Jennifer G. Robinson, Robert D. Brook et al. · New England Journal of Medicine · 2016 · 757 citations · Full text

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Robert S. Rosenson, H. Bryan Brewer, M. John Chapman et al. · Clinical Chemistry · 2011 · 505 citations